Now I have all the information I need. Let me produce the final consolidated review.

## Summary

This paper proposes **VQ-Transplant**, a framework for plug-and-play replacement of VQ modules in pre-trained visual tokenizers without retraining the full encoder-decoder pipeline. The method has two stages: (1) substituting the VQ module while freezing encoder-decoder parameters, and (2) lightweight decoder adaptation (5 epochs) to fix distribution mismatch between the new quantizer and the frozen decoder. The paper also proposes **MMD VQ**, a quantization method using maximum mean discrepancy for distribution alignment. Evaluations use the pre-trained VAR tokenizer across 5 VQ algorithms, multiple codebook sizes (4096–65536), and 4 datasets (ImageNet-1k, FFHQ, CelebA-HQ, LSUN-Churches).

## Strengths

1. **The core idea is practically motivated and clearly framed.** The observation that VQ module development is gated by the need to retrain entire encoder-decoder pipelines is genuine and well-articulated. The two-stage solution — VQ substitution followed by lightweight decoder adaptation — is simple, intuitive, and directly addresses the stated problem.

2. **Computational savings are large and concretely quantified (Table 1).** VQ-Transplant uses 2×A100 GPUs for 22 hours versus 16×A100 for 60 hours for the original VAR, yielding a ~21.8× reduction in GPU-hours. These numbers represent a practically meaningful reduction in the resource barrier for VQ research.

3. **Broad empirical evaluation across 5 VQ algorithms (Vanilla, EMA, Online, Wasserstein, MMD)** under multi-scale and fixed-scale configurations, multiple codebook sizes (4096–65536), and four datasets. This breadth gives a fairly complete picture of how the framework behaves across conditions.

4. **The adaptation epoch analysis (Tables 4, 5, Figure 3) provides practically useful information.** Showing that r-FID continues to improve up to 20 epochs, and that the gap between codebook sizes widens with more adaptation, helps practitioners understand the trade-offs involved.

## Weaknesses

### Fatal
None.

### Major
- **MMD VQ is not empirically differentiated from Wasserstein VQ despite being presented as a separate contribution (lines 49, 105).** The paper claims MMD VQ "makes no parametric assumptions and robustly aligns feature and codebook distributions even for complex, non-Gaussian data" whereas Wasserstein VQ "critically relies on Gaussian distribution assumptions" (line 61). This theoretical distinction is never empirically tested. Across all experiments (Tables 3, 7–10), MMD and Wasserstein produce near-identical results with differences of 0.01–0.06 r-FID that go in both directions. On FFHQ (Table 8, adaptation), Wasserstein VQ outperforms MMD VQ by 0.18–0.16 r-FID. No experiment demonstrates a domain where MMD's nonparametric advantage materializes. The empirical case for MMD VQ as a distinct improvement over Wasserstein VQ is unsubstantiated.

### Minor
- **No variance or confidence intervals are reported for any metric.** Given that differences between methods (e.g., MMD vs. Wasserstein) are often 0.01–0.06 r-FID, the reader cannot assess which differences are meaningful versus arising from random seed variation. This is especially important for the paper's central quantitative comparisons.

- **The cross-dataset "state-of-the-art" claim (Section 5.3) is overly broad.** Tables 8–10 compare VQ-Transplant (with decoder adaptation only) against baselines fully trained from scratch on each dataset. While VQ-Transplant achieves better raw numbers, the comparison conflates the benefit of the VQ-Transplant framework with the benefit of inheriting a powerful pre-trained VAR backbone. A controlled comparison — e.g., fine-tuning the original VAR tokenizer on these datasets — would be needed to substantiate a "state-of-the-art" claim.

- **The speedup comparison in Table 1 uses different datasets:** VAR was trained on OpenImages (a larger, more diverse dataset) while VQ-Transplant is trained on ImageNet-1k. Some fraction of the 21.8× speedup may come from the smaller dataset rather than the framework alone.

- **The from-scratch training comparison (Table 6) is not particularly informative.** The paper itself acknowledges the result is "expected" because discrete tokenizers "typically require hundreds of epochs" (line 265). Comparing against 5–7 epochs of from-scratch training does not provide a meaningful baseline. The paper would be stronger without this table or with a more informative framing.

### Trivial
None.

## Nice-to-Haves
- Substantiate MMD VQ's claimed advantage over Wasserstein VQ with a targeted experiment (e.g., synthetic non-Gaussian data) or re-scope MMD VQ as a variant alongside Wasserstein VQ rather than a separate novel contribution.
- Run the original VAR tokenizer with a larger codebook (K=8192) to directly test whether the improvement from VQ-Transplant is due to the framework or to the larger codebook alone.
- Control for dataset size when reporting the speedup (Table 1) to isolate the framework's contribution.
- Include controlled cross-dataset baselines (e.g., fine-tuned original VAR) to substantiate the "state-of-the-art" claim.

## Removed Points
*These points are flagged to be removed; treat them with caution.*
- **Criticism about Table 2 baselines not being apples-to-apples** (mixing different token counts and architectures) — **REMOVED**: This is standard practice for overall SOTA comparison tables in this field. The paper's primary comparison against VAR (same architecture, same tokenizer family) is fair and clearly separated from the broader literature context.
- **Criticism about LDM-16 results being deferred to Appendix D** — **REMOVED**: Per hard rule, the parser strips appendix content from all papers. The paper explicitly references the LDM-16 experiment and notes its limitations.
- **"τ-FID"/"τ-IS" notation in Tables 7–10** — **REMOVED**: This is almost certainly a LaTeX/parser encoding artifact. The main text and other tables consistently use "r-FID" and "r-IS."
- **Claim that the from-scratch comparison is a "straw man that undermines the paper's evidentiary standards"** — **REMOVED extreme framing**: The paper transparently states the result is expected. The comparison is retained as a minor weakness (uninformative), but there is no evidence of intent to mislead.
- **Criticism about unspecified γ for non-distribution-matching VQ modules in Equation (3)** — **REMOVED**: This is a minor specification detail that could be clarified in a revision but does not affect the paper's claims or conclusions.

## Novel Insights
None beyond the paper's own contributions.

## Suggestions
- **Reframe MMD VQ as a variant rather than a separate contribution.** The empirical evidence does not support MMD VQ being superior to Wasserstein VQ. Presenting it as "MMD-based distribution matching, which performs comparably to Wasserstein-based matching" would be more accurate and strengthen the paper's credibility.
- **Add error bars or confidence intervals** to the main quantitative comparisons, especially where differences between methods are small (≤0.06 r-FID).
- **Remove or relegate Table 6** (from-scratch comparison) to the appendix, or reframe it to focus on the cost to reach a given performance threshold rather than a direct quality comparison at 5–7 epochs.
- **Quality the cross-dataset claims** by noting that the comparisons are against from-scratch training, and that the pre-trained backbone provides an initialization advantage.

## Score and Decision

The VQ-Transplant framework itself is a solid, practically motivated contribution with clear experimental support. The ~21.8× computational savings are substantial and well-quantified, and the empirical evaluation is broad. However, the paper significantly overclaims in two areas: (1) MMD VQ is presented as a novel method with claimed advantages over Wasserstein VQ that are never demonstrated empirically, and (2) the cross-dataset "state-of-the-art" claims lack proper controlled baselines. The core VQ-Transplant contribution remains independently valuable, but these over-claims erode the paper's credibility. With appropriate re-scoping of the MMD VQ claims and addition of a controlled baseline for the cross-dataset experiments, this would be a stronger contribution.

MY FINAL SCORE: <score>6</score>
MY FINAL DECISION: <decision>Accept</decision>